Skip to main content

Table 2 Baseline characteristics of the study participants according to phenotype obesity (n = 8,360)

From: Association between obesity phenotypes and non-alcoholic fatty liver: a large population- based study

Characteristic

Metabolically healthy

Metabolically unhealthy

P value *

Non-obese

(n = 3,949)

Obese

(n = 1,158)

Non-obese

(n = 2,109)

Obese

(n = 1,144)

Mean ± SD / n (%)

Age (year)

46.36 ± 8.23

45.98 ± 7.51

49.98 ± 8.40

49.12 ± 7.77

< 0.001

Sex

     

Men

1959 (49.61)

253 (21.85)

1045 (49.55)

312 (27.27)

< 0.001

Women

1990 (50.39)

905 (78.15)

1064 (50.45)

832 (72.73)

Socioeconomic status

     

Low

1373 (34.77)

374 (32.30)

717 (34.00)

407 (35.58)

0.008

Moderate

1287 (32.59)

404 (34.89)

684 (32.43)

421 (36.80)

High

1289 (32.64)

380 (32.82)

708 (33.57)

316 (27.62)

Physical activity

     

Low

1082 (27.40)

355 (30.66)

700 (33.19)

409 (35.75)

< 0.001

Moderate

1858 (47.05)

642 (55.44)

1010 (47.89)

608 (53.15)

High

1009 (25.55)

161 (13.90)

399 (18.92)

127 (11.10)

Smoking status

     

Never

3228 (82.14)

1044 (90.63)

1667 (79.42)

988 (86.74)

< 0.001

Current smoker

412 (10.48)

46 (3.99)

232 (11.05)

58 (5.09)

Former smoker

290 (7.38)

62 (5.38)

200 (9.53)

93 (8.17)

Comorbidity

     

Dyslipidemia

980 (24.82)

278 (24.01)

1615 (76.58)

781 (68.27)

< 0.001

T2DM

66 (8.92)

31 (4.19)

387 (52.30)

256 (34.59)

< 0.001

CVD

258 (17.39)

121 (8.15)

671 (45.22)

434 (29.25)

< 0.001

Hypertension

224 (16.51)

68 (5.01)

647 (47.68)

418 (30.80)

< 0.001

Renal failure

24 (0.61)

7 (0.60)

34 (1.61)

20 (1.75)

< 0.001

Anthropometric indices

     

BMI (kg/m2)

25.10 ± 2.87

33.12 ± 3.10

26.48 ± 2.33

33.36 ± 3.29

< 0.001

WHR

0.92 ± 0.05

0.99 ± 0.05

0.94 ± 0.05

0.99 ± 0.06

< 0.001

BFM (kg)

20.55 ± 6.32

36.69 ± 6.77

23.05 ± 5.27

36.70 ± 7.31

< 0.001

VFA (cm2)

99.11 ± 37.69

183.61 ± 33.34

112.91 ± 33.490

182.61 ± 35.03

< 0.001

Liver enzymes

     

AST (mg/dl)

21.14 ± 8.34

20.42 ± 10.82

21.81 ± 8.47

21.21 ± 8.48

< 0.001

ALT (mg/dl)

22.81 ± 12.93

24.01 ± 15.53

26.73 ± 15.46

26.40 ± 14.24

0.001

GGT (mg/dl)

21.49 ± 17.10

23.33 ± 18.77

28.19 ± 23.04

28.27 ± 20.78

< 0.001

Dietary intake

     

Energy intake (Kcal/day)

2538.45 ± 738.18

2515.82 ± 735.36

2469.36 ± 757.90

2469.72 ± 729.92

0.004

Whole grains (gr/day)

9.43 ± 0.20

10.25 ± 0.36

10.37 ± 0.27

10.93 ± 0.36

0.006

Refined grains (gr/day)

511.44 ± 2.34

480.36 ± 4.33

502.13 ± 3.21

492.29 ± 4.36

< 0.001

Dairy (gr/day)

418.38 ± 5.50

476.34 ± 10.15

451.66 ± 7.53

471.31 ± 10.22

< 0.001

Vegetables (gr/day)

442.84 ± 3.73

499.20 ± 6.89

480.01 ± 5.11

511.91 ± 6.94

< 0.001

Fruits (gr/day)

251.21 ± 2.99

306.96 ± 5.52

269.01 ± 4.10

304.99 ± 5.55

< 0.001

Meat (gr/day)

71.71 ± 0.75

70.04 ± 1.38

76.31 ± 1.02

74.05 ± 1.39

0.004

Egg (gr/day)

21.21 ± 0.28

17.84 ± 0.52

18.98 ± 0.39

17.13 ± 0.53

< 0.001

Legumes (gr/day)

32.61 ± 0.44

31.63 ± 0.81

33.51 ± 0.60

31.98 ± 0.82

0.236

Sweets and desserts (gr/day)

59.38 ± 0.55

56.73 ± 1.02

53.18 ± 0.76

50.26 ± 1.03

< 0.001

Soft drinks (gr/day)

35.34 ± 0.82

34.59 ± 1.52

34.86 ± 1.13

33.54 ± 1.52

0.774

Hydrogenated fats (gr/day)

19.90 ± 0.29

20.44 ± 0.54

18.37 ± 0.40

18.39 ± 0.54

0.008

Fatty acid total saturated (gr/day)

28.10 ± 0.15

29.03 ± 0.27

27.61 ± 0.20

27.62 ± 0.27

0.001

Fatty acid total trans (gr/day)

0.27 ± 0.01

0.28 ± 0.01

0.26 ± 0.02

0.25 ± 0.01

0.201

Cholesterol (gr/day)

271.63 ± 1.65

264.22 ± 3.05

269.62 ± 2.26

260.42 ± 3.10

0.005

Butter (gr/day)

3.75 ± 0.07

3.64 ± 0.13

3.27 ± 0.10

3.05 ± 0.13

0.001

Salt (gr/day)

4.26 ± 0.04

4.44 ± 0.08

4.06 ± 0.06

4.12 ± 0.08

0.007

Sugar (gr/day)

136.65 ± 0.60

144.21 ± 1.10

136.42 ± 0.82

140.28 ± 1.10

0.001

  1. *P-values were obtained one-way ANOVA and Chi square.
  2. Abbreviation CVD cardiovascular disease; T2DM type 2 diabetes mellitus; ALT alanine aminotransferase; AST aspartate aminotransferase; GGT gamma-glutamyl transferase; BMI body mass index; WHR waist hip ratio; VFA visceral fat area; BFM Body fat mass; SES socioeconomic status